MEI Pharma, Inc. (NASDAQ:MEIP) (the "Company") today mailed the following letter to shareholders, encouraging them to vote FOR the pending transaction with Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)
Phase 2 topline data readout for prevention of post-surgical abdominal adhesions on track for Q2 2023
Strong balance sheet with sufficient cash expected to